2H-Quinolizine-3-carboxaldehyde,6-(3-furanyl)-1,6,7,8,9,9a-hexahydro-9-(hydroxymethyl)-, (6S,9R,9aS)- (119459-68-6)

Identification
Name:	2H-Quinolizine-3-carboxaldehyde,6-(3-furanyl)-1,6,7,8,9,9a-hexahydro-9-(hydroxymethyl)-, (6S,9R,9aS)-
Synonyms:	2H-Quinolizine-3-carboxaldehyde,6-(3-furanyl)-1,6,7,8,9,9a-hexahydro-9-(hydroxymethyl)-, [6S-(6a,9b,9ab)]-; (+)-Nuphacristine; NSC 625620; Nuphacristine
CAS:	119459-68-6
Molecular Formula:	C15H19 N O3
Molecular Weight:	261.3163
InChI:	InChI=1/C15H19NO3/c17-8-11-1-3-14-12(9-18)2-4-15(16(14)7-11)13-5-6-19-10-13/h5-8,10,12,14-15,18H,1-4,9H2
Molecular Structure:
Properties
Flash Point:	213.1°C
Boiling Point:	428.7°Cat760mmHg
Density:	1.23g/cm³
Refractive index:	1.591
Flash Point:	213.1°C
Safety Data

Other Product

Dispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine]-4,4''-diol,6,6''-di-3-furanyldodecahydro-9,9''-dimethyl-, (2'S,3''S,4S,4''R,6S,6''S,9R,9''R,9aS,9''aS)-
Dispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine],6,6''-di-3-furanyldodecahydro-9,9''-dimethyl-,(2'R,3''S,6S,6''S,9R,9''R,9aS,9''aS)- (9CI)
Dispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine],6,6''-di-3-furanyldodecahydro-9,9''-dimethyl-,(2'S,3''S,6S,6''S,9R,9''R,9aS,9''aS)-
(3S,4'S)-6α,6''α-Di(3-furanyl)-1,6,7,8,9,9aβ,1'',6'',7'',8'',9'',9''aβ-dodecahydro-4α-hydroxy-9β,9''β-dimethyldispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine]
Spiro[5H,6H-5a,9a-(iminomethano)-1H-cyclopent[ f]indolizine-7(8H),3'(2'H)-pyrano[2,3-g]- indole]-2',5,10-trione,1',2,3,7',8a,9- hexahydro-6-hydroxy-7',7',8,8-tetramethyl-,(3'R,5aR,6S,8aS,9aS)-
Spiro[1H-7,9a-methanocyclohepta[c]pyran-4(3H),1'-[3]cyclohexene]-6'-carboxaldehyde,9-(acetyloxy)-4a,5,6,7,8,9-hexahydro-5',5'-dimethyl-8-methylene-1,2'-dioxo-,(1'S,4aS,6'R,7R,9R,9aS)-
Spiro[4H,8H-[1,4]dioxepino[2,3-g]indole-8,2'(3'H)-[1H,4H-3a,9a](iminomethano)cyclopenta[b]quinolizine]-9,11'(10H)-dione,6',7',8',9',10',10'a-hexahydro-1',1',4,4,12'-pentamethyl-,(2'R,3'aS,9'aS,10'aS)-
Spiro[1H-7,9a-methanocyclohepta[c]pyran-4(3H),1'-cyclohexane]-2'-carboxaldehyde,9-(acetyloxy)hexahydro-5,6'-dihydroxy-3',3'-dimethyl-8-methylene-1-oxo-,(1'S,2'R,4aS,5S,6'S,7S,9R,9aS)-
6H-3,5a-Epoxy-1-benzoxepin-3(2H)-ol,6,6'-(1,2-ethanediyl)bis[hexahydro-2,2,6,7-tetramethyl-,(3S,3'S,5aS,5'aS,6S,6'S,7S,7'S,9aS,9'aS)- (9CI)
Spiro[cyclohexane-1,4'(3'H)-[1H-7,9a]- methanocyclohepta[c]pyran]-2-carboxaldehyde,6-(acetyloxy)hexahydro-3,3,8'-trimethyl-1',9'- dioxo-,(1S,2R,4'aS,6S,7'R,8'S,9'aS)-
2H-Quinolizin-2-ol,6-(3-furanyl)octahydro- 3,9-dimethyl-,(2S,3R,6S,9R,9aS)-
1H-Pyrrole-2-carboxylicacid,(3S,4R,4aR,6S,6aS,7S,8S,8aR,8bS,9R,9aS)-dodecahydro-4,6,7,8b,9a-pentahydroxy-9-(hydroxymethyl)-3,6a-dimethyl-7-(1-methylethyl)-6,9-methanobenzo[1,2]pentaleno[1,6-bc]furan-8-ylester (9CI)
3-Pyridinecarboxylicacid,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester (9CI)
3-Furancarboxylic acid,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-10-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester
3-Furancarboxylic acid,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5,10-diylester (9CI)
3-Furancarboxylic acid,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester, (2E)-
Naphtho[1,2-c]furan-1(3H)-one,7-(acetyloxy)- 4,5,5a,6,7,8,9,9a-octahydro-9-hydroxy-6,9adimethyl- 6-(4-methyl-3-oxopentyl)-,(5aS,- 6S,7S,9R,9aS)-
Naphtho[1,2-c]furan-1(3H)-one,7-(acetyloxy)- 4,5,5a,6,7,8,9,9a-octahydro-9-hydroxy-6,9adimethyl- 6-(4-methyl-3-pentenyl)-,(5aS,6S,- 7S,9R,9aS)-
4H-Quinolizin-4-one,9-ethyloctahydro-6-(hydroxymethyl)-,(6S,9R,9aS)-(9CI)